Clinical Trial Update: A Study to Establish the Feasibility of Biolen for the Local Delivery of Bicalutamide in Patients With Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase 1 feasibility study evaluating Biolen for local delivery of bicalutamide in prostate cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Biolen
• bicalutamide (bicalutamide)

Snippet

Sponsor: Alessa Therapeutics Inc. | Conditions: Prostate Adenocarcinoma, Lower Urinary Tract Symptoms | Phase 1 | Status: COMPLETED